p16 expression was examined in 4/9 NEC-like G3NETs and 9/31 G3NETs without NEC-like features and a strong expression was observed in 3/4 (75%) of NEC-like G3NETs but none in the latter group. Here, CDKN2A is linked to neuroendocrine carcinoma.